Chart

4  MANAGEMENT

MANAGEMENT CONTRACTS AND RULES REGARDING OUTSIDE MANDATES

No agreements between the Company and third parties that are not part of the Tecan Group were entered into or renewed in the year under review for the purpose of delegating management responsibilities.

 

According to the Articles of Incorporation, the permitted number of other mandates of the members of the Management Board in the highest executive management or bodies of legal entities outside of the Company’s group is limited to two mandates in listed and four mandates in non-listed companies, foundations and other legal entities that are registered in the commercial register. Mandates in different legal entities of the same group (including in joint ventures directly or indirectly owned by such a group or the Company that are not consolidated) are counted as one mandate per group, but may not exceed the number of 20 additional mandates if counted separately. Short-term transgressions of these maximum numbers by a maximum of two mandates per category are permitted during a maximum period of six months. Mandates held by members of the Management Board by order of the Company shall not be subject to the limitations set out above.

 

1 | Dr. Achim von Leoprechting

Chief Executive Officer (CEO)

Head of the Partnering Business division a.i.

 

 

Member since 2013 

Joining Tecan in 2013 

1968 

German citizen

PhD in Biology (University of Freiburg, Germany) 

 

Professional background: 

1999 to 2002 Different positions in product management at Packard Bioscience, today part of PerkinElmer; 2002 to 2013 Several management positions and professional positions at PerkinElmer Inc. (NYSE: PKI), including Vice President and General Manager In Vitro Solutions.

 

Other activities: 

Analytical, Life Science and Diagnostics Association (ALDA), Member of the Board

2 | Ulrich Kanter

Executive Vice President

Head of the Division Development and Operations 

 

Member since 2014 

Joining Tecan in 2014 

1963

German citizen

Mechanical Engineer (Berufsakademie Mannheim, Germany) and Diploma in Business Administration (Verwaltungs- und Wirtschaftsakademie at the J.W. Goethe University Frankfurt, Germany)

 

Professional background: 

1995 to 2000 Vice President, Operations and Global Supply Chain Manager at AVL Medizintechnik (acquired by Roche Diagnostics in 2000); 2000 to 2014 diverse positions with increasing management responsibility at Roche Diagnostics, most recently as General Manager and Head of Research & Development in Graz, Austria.

 

Other activities: 

Toolpoint for Lab Science, member of the Board

3 | Dr. Klaus Lun

Executive Vice President

Head of the Life Sciences Business division

 

Member since 2013

Joining Tecan in 2013

1972

Italian citizen

M.Sc. Biology (University of Tübingen, Germany), Dr. rer. nat. in Neurobiology (equiv. Ph.D., University of Heidelberg, Germany), MBA (University of Mannheim, Germany) 

 

Professional background: 

2002 to 2007 Variety of positions at the Lonza Group, most recently as a Senior Project Manager, 2007 to 2011 Director Business Development at Danaher Group (Leica Microsystems); 2011 to 2013 Several management positions at Molecular Devices Inc. (Danaher Group), most recently as Vice President Drug Discovery and Bioresearch und Vice President Global Product Marketing, 2013 to 2017 Executive Vice President, Head of Corporate Development, Tecan Group.

 

Other activities: 

None

4 | Tania Micki

Chief Financial Officer (CFO)

 

Member since 2020 

Joining Tecan in 2020 

1971

French and Swiss citizen

MBA General Management ­(INSEAD, Fontainebleau, France)

Graduated ESCP (École Supérieure de Commerce de Paris) in Paris, France with major Finance/Audit/Accounting

BA in Russian (University Paris Nanterre, France)

 

Professional background: 

1999 to 2006 various financial positions at General Mills; 2006 to 2009 Vice President Finance, Planning and Analysis Europe, Gate Group; 2009 to 2010 Seed Supply Finance Lead EMEA, Monsanto; 2010 to 2020 variety of positions at Sulzer AG, most recently as Chief Risk Officer and Group Internal Audit Head, other positions included CFO Global Markets in a group-wide function

 

Other activities: 

None

5 | Dr. Wael Yared

Executive Vice President

Chief Technology Officer (CTO)

Head Research and ­Development

 

Member since 2019

Joining Tecan in 2019

1962

US citizen

PhD in Robotics (Massachusetts Institute of Technology), Cambridge, MA, USA

 

Professional background: 

1995 to 2002 Different positions at Arthur D. Little, Inc. and Cambridge Strategic Management Group; 2003 to 2010 Vice President, Research & Development at VisEn Medical, Inc., today part of PerkinElmer; 2010 to 2016 Vice President, Research & Development at PerkinElmer Life Sciences & Technology; 2016 to 2018 Chief Technology Officer & Vice President, Corporate Development at BioAnalytix, Inc.

 

Other activities: 

None

6 | Markus Schmid

Executive Vice President

Head of Corporate Human Resources & Internal Commmunications

 

Member since 2011 

Joining Tecan in 2011 

1968

Swiss citizen

Master in Psychology and Journalism (University of Freiburg, Switzerland) 

 

Professional background: 

1990 to 1993 Consultant for an occupational pensions fund at an insurance Company; 1994 to 1998 teacher and instructor at various educational levels and has held various consulting positions; 1998 to 2011 Partner and operations manager at MANRES AG, Zurich.

 

Other activities: 

None

7 | ERIK NORSTRÖM

Executive Vice President 

Head of Corporate Development

 

Member since 2017

Joining Tecan in December 2017

1973

Swedish and Swiss citizen

M.Sc. in Chemical Engineering (Chalmers University of Technology, Göteborg, Sweden)

B.Sc. in Business Administration (Göteborg University of Economics and Commercial Law, Sweden)

 

Professional background: 

2001 to 2008 Corporate Development Director at F. Hoffmann-La Roche AG, Basel; 2008 to 2012 Head of M&A and alliances at Nobel Biocare AG, Zürich; 2012 to 2015 Head of Corporate Development and M&A Member of the Corporate Leadership Team at Nobel Biocare AG, Zürich; 2015 to 2017 Corporate Vice President strategic development and M&A Member of the Corporate Leadership team at Chr. Hansen a/s, Copenhagen, Denmark.

 

Other activities: 

Andrew Alliance S.A., Member of the Board (until January 2020) 

8 | Andreas Wilhelm

Executive Vice President

General Counsel and Secretary of the Board of Directors of Tecan Group Ltd.

 

Member since 2012 

Joining Tecan in 2004 

1969

Swiss citizen

Studies of law (University Berne, Switzerland), Master of Law Program (Boston University, USA), Admitted to the Swiss Bar 

 

Professional background: 

1993 Judicial Clerk at District Court of Nidau; 1994 to 1995 Legal Internship at Notter & Partner in Berne; 1996 to 1999 Attorney-at-law at Grüninger Hunziker Roth Rechtsanwälte in Berne; 2000 to 2004 Attorney-at-law at Bär & Karrer in Zurich; since 2004 Head Legal Affairs and Secretary of the Board of Directors of Tecan Group Ltd. 

 

Other activities: 

None

Members who left Tecan

DR. DAVID MARTYR

Chief Executive Officer

until March 2019

 

DR. RUDOLF EUGSTER

Chief Financial Officer

until February 2019

EN DE